GLP1R and diabetes mellitus: However, the percentage of patients with type 2 diabetes treated with a GLP-1 RAs has increased from 3.2% to 10.7% from 2015 to 2020 in the United States, with yearly total prescription of more than 63 million.4 The prevalence of diabetes has significantly increased worldwide over the last few decades.